In global health, true breakthroughs are rare. When they come, their value is measured not in laboratories, but in the lives they save.
Today, that test centres on lenacapavir – sometimes called Len – a long-acting HIV prevention drug that could transform the global epidemic, particularly for adolescent girls and young women, who remain at its heart.
